Larson Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Larson Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.1K	Buy	1,391 +154	+12%	+$5.13K	﹤0.01%	1545
2026 Q1	$37.3K	Buy	1,237 +49	+4%	+$1.58K	﹤0.01%	1516
2025 Q4	$37.1K	Buy	1,188 +100	+9%	+$2.46K	﹤0.01%	1397
2025 Q3	$22K	Sell	1,088 -3	-0.3%	-$53	﹤0.01%	1593
2025 Q2	$18.3K	Buy	1,091 +233	+27%	+$3.76K	﹤0.01%	1529
2025 Q1	$13.2K	Buy	858 +29	+3%	+$518	﹤0.01%	1530
2024 Q4	$18.3K	Buy	829 +150	+22%	+$2.73K	﹤0.01%	1253
2024 Q3	$12.2K	Hold	679	–	–	﹤0.01%	1396
2024 Q2	$11K	Hold	679	–	–	﹤0.01%	1233
2024 Q1	$9.58K	Hold	679	–	–	﹤0.01%	1053
2023 Q4	$7.09K	Hold	679	–	–	﹤0.01%	1102
2023 Q3	$6.93K	Buy	679 +87	+15%	+$810	﹤0.01%	1094
2023 Q2	$4.46K	Hold	592	–	–	﹤0.01%	1126
2023 Q1	$5.24K	Buy	592 +217	+58%	+$2.15K	﹤0.01%	1076
2022 Q4	$3.42K	Hold	375	–	–	﹤0.01%	1106
2022 Q3	$3K	Hold	375	–	–	﹤0.01%	1074
2022 Q2	$3K	Hold	375	–	–	﹤0.01%	986
2022 Q1	$4K	Hold	375	–	–	﹤0.01%	840
2021 Q4	$3K	Hold	375	–	–	﹤0.01%	915
2021 Q3	$4K	Hold	375	–	–	﹤0.01%	727
2021 Q2	$4K	Hold	375	–	–	﹤0.01%	661
2021 Q1	$4K	Hold	375	–	–	﹤0.01%	654
2020 Q4	$4K	Hold	375	–	–	﹤0.01%	587
2020 Q3	$3K	Hold	375	–	–	﹤0.01%	571
2020 Q2	$5K	Hold	375	–	–	﹤0.01%	489
2020 Q1	$3K	Buy	+375	New	+$3.84K	﹤0.01%	412

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Larson Financial Group's TEVA Position: Q2 2026 in Review

Larson Financial Group increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $5.13K and bringing the position to 1,391 shares worth $47.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Larson Financial Group first reported a position in TEVA in Q1 2020 and has held it in 26 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Larson Financial Group held 1,391 shares of Teva Pharmaceuticals worth $47.1K as of Q2 2026.
Larson Financial Group bought 154 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.13K.
Teva Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1545 holding.
Larson Financial Group first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.